The non-synonymous genetic variant rs2257212 (SLC15A1 c.1048C>T, p.L350F) was associated with prolonged progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC) treated with sorafenib. The gene discussed is SLC15A1; the disease is hepatocellular carcinoma.